Hogan Lovells Advised Altavant Sciences in Its Acquisition of Onspira Therapeutics
January 09, 2020
January 09, 2020
NEW YORK, Jan. 9 -- Hogan Lovells, a multinational law firm, issued the following news release:
International law firm Hogan Lovells advised clinical-stage biopharmaceutical company Altavant Sciences in its acquisition of Onspira Therapeutics, a private drug development company similarly focused on therapeutics for rare pulmonary diseases.
This acquisition expanded Altavant's pipeline to include OSP-101, a novel inhaled interleukin-1 receptor antagonist (IL-1Ra) with US . . .
International law firm Hogan Lovells advised clinical-stage biopharmaceutical company Altavant Sciences in its acquisition of Onspira Therapeutics, a private drug development company similarly focused on therapeutics for rare pulmonary diseases.
This acquisition expanded Altavant's pipeline to include OSP-101, a novel inhaled interleukin-1 receptor antagonist (IL-1Ra) with US . . .